Supportive care: Patient expectations, availability and uptake
نویسندگان
چکیده
منابع مشابه
Supportive care of the cancer patient.
• Vomiting=Emesis • Drugs used to prevent/treat nausea and vomiting=anti‐emetics • N & V can be associated with a variety of clinical conditions and drugs. This discussion will focus on Chemotherapy Induced Nausea and Vomiting (CINV) • Approximately 70‐80% of all cancer patients receiving chemotherapy experience nausea and vomiting. Patients often experience more nausea than vomiting. Pathophys...
متن کاملPatient expectations regarding eye care: development and results of the Eye Care Expectations Survey (ECES).
OBJECTIVE To develop an instrument (the Eye Care Expectations Survey [ECES]) that can identify and quantify the expectations of patients visiting eye care providers. METHODS A total of 202 patients attending 4 ophthalmology practices affiliated with Duke University Eye Center enrolled in the study. All participants completed the pilot version of the ECES, which was developed through a review ...
متن کاملSupportive care.
For cancer patients, quality of life and satisfaction with care are not only related to patient treatment facilities, but also to ambulatory care. Therefore, the goal of ambulatory care should be to prevent predictable morbidities, to eliminate residual morbidities when possible, to control symptoms, and to lessen discomfort when cure is not likely. Truly multidisciplinary services should be av...
متن کاملSupportive care.
Aim: The majority of cancer patients develop cancer cachexia (CC). CC is a debilitating and life-threatening, multifactorial condition that is characterized by altered metabolism and reduced food intake, contributing to weight loss (mainly lean body mass). Existing treatment approaches are limited in their ability to treat CC, while too little is currently done to prevent it. Surveys were carri...
متن کاملSupportive Care of the Patient With Advanced Pancreatic Cancer
Pancreatic cancer represents only 3% of cancer diagnoses in the United States, with an estimated 43,920 new cases diagnosed in 2012, yet it remains the fourth leading cause of cancer deaths, with an estimated 37,390 deaths in the same year.[1] Despite the availability of newer and better antineoplastic combinations, the 5-year survival rate for all stages of pancreatic cancer remains dismal at ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2018
ISSN: 0923-7534
DOI: 10.1093/annonc/mdy300.083